48
Participants
Start Date
January 25, 2018
Primary Completion Date
April 30, 2022
Study Completion Date
February 19, 2023
Low molecular weight heparin
Patients included in this study group will receive 3,500 IU / 0.2 ml / day of Bemiparina sc, from inclusion to delivery (estimated median of 5-6 weeks, with a maximum of 13 weeks).
Placebos
Patients included in this study group will placebo (same presentation as the active drug), from inclusion to delivery (estimated median of 5-6 weeks, with a maximum of 13 weeks).
Hospital Sant Joan de Déu, Esplugues de Llobregat
Servicio de Asesoría a la Investigación y Logística SL
OTHER
Fundació Sant Joan de Déu
OTHER